Our research aims at unravelling T-cell co-stimulatory and co-inhibitory pathways and the roles they play in T-cell responses. As dysregulation of these pathways is an important mechanism of tumor evasion, a deeper understanding could lead to future improvements in cancer immunotherapy.
I obtained my Bachelor in Biopharmaceutical Sciences at Leiden University, finishing with a thesis looking at the role of NKT type II cells in atherosclerosis. I continued with a Master in Infection Biology at Uppsala University in Sweden. Here I did my thesis on investigating pan-Flavivirus protease inhibitors. In August 2022 I joined the group of Ramon Arens.